resources

Medicamen Organics Ltd.

NSE: MEDIORG

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

24.55-0.9 (-3.54%)

23 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Medicamen Organics Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2024	2025
Annual Reports	—	—
Quarterly Results	Sept	—
Conference Calls	25Nov	10Jun
Presentations	23Nov	4Jun

Corporate Announcements and Regulatory Filings

Medicamen Organics Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under SEBI (Depositories and Participants) Regulations, 20188 Oct 2026
Medicamen Organics Limited has informed the Exchange about Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended on September 30, 2026
Change in Auditors26 Sept 2026
Medicamen Organics Limited has informed the Exchange regarding Change in Auditors of the company.
Shareholders meeting26 Sept 2026
Medicamen Organics Limited has informed the Exchange regarding Proceedings of undefined held on September 25, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
General Updates2 Sept 2026
Medicamen Organics Limited has informed the Exchange about the letter dispatched to the Members of the Company containing the exact path to access the Annual Report for the F.Y. 2025-26.
Trading Window2 Sept 2026
Medicamen Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Copy of Newspaper Publication1 Sept 2026
Medicamen Organics Limited has informed the Exchange about Copy of Newspaper Publication for information regarding dispatch of Annual Report for the Financial Year 2025-26 and Notice of the 31st Annual General Meeting
Shareholders meeting31 Aug 2026
Medicamen Organics Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026 along with the Annual Report for the financial year 2025-26.
Copy of Newspaper Publication30 Aug 2026
Medicamen Organics Limited has informed the Exchange about Copy of Newspaper Publication regarding information before dispatch of notice of the 31st Annual General Meeting and Annual Report for the financial year ended March 31, 2026
Outcome of Board Meeting27 Aug 2026
Medicamen Organics Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026.
Outcome of Board Meeting27 Aug 2026
Medicamen Organics Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026.
Cessation21 Jul 2026
Medicamen Organics Limited has informed the Exchange regarding Cessation of Mr Brijesh Kumar Chaubey as Executive Director of the company w.e.f. July 20, 2026.
Certificate under SEBI (Depositories and Participants) Regulations, 20189 Jul 2026
Medicamen Organics Limited has informed the Exchange about the Certificate received under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the qaurter ended June 30, 2026.
General Updates9 Jun 2026
Medicamen Organics Limited has informed the Exchange about General Updates
Committee Meeting Updates9 Jun 2026
Medicamen Organics Limited has informed the Exchange regarding the Outcome of the Management Committee Meeting held on June 09, 2026.
Disclosure under SEBI Takeover Regulations3 Jun 2026
Ritu Gupta has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Disclosure under SEBI Takeover Regulations3 Jun 2026
Bal Kishan Gupta has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Disclosure under SEBI Takeover Regulations3 Jun 2026
Ishaan Gupta has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Disclosure under SEBI Takeover Regulations3 Jun 2026
Medicamen Organics Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Updates30 May 2026
Medicamen Organics Limited has informed the Exchange regarding 'Non-applicability of Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026, under Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Updates29 May 2026
Medicamen Organics Limited has informed the Exchange regarding the approval of the amended Code of Practices and Procedures for fair disclosure of UPSI.

Frequently Asked Questions

Where can I download the annual report of Medicamen Organics Ltd.?

Annual reports of Medicamen Organics Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Medicamen Organics Ltd.?

Quarterly earnings results and presentations of Medicamen Organics Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Medicamen Organics Ltd. publish earnings call transcripts?

Earnings call transcripts of Medicamen Organics Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Medicamen Organics Ltd.?

Investor presentations and annual day presentations of Medicamen Organics Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Medicamen Organics Ltd.?

Corporate announcements and regulatory filings of Medicamen Organics Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Medicamen Organics Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Medicamen Organics Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Medicamen Organics Ltd.?

The ISIN (International Securities Identification Number) of Medicamen Organics Ltd. is INE0PE401018. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Medicamen Organics Ltd. listed?

Medicamen Organics Ltd. is listed on NSE and BSE. The NSE symbol is MEDIORG and the BSE code is -.

Where can I find the shareholding pattern of Medicamen Organics Ltd.?

The quarterly shareholding pattern of Medicamen Organics Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Medicamen Organics Ltd. on Sharpely?

Share price data for Medicamen Organics Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.